QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (55) Citing Articles via Google Scholar Google Scholar Articles by Georgescu, D. Articles by DiLeone, R. J. Search for Related Content PubMed PubMed Citation Articles by Georgescu, D. Articles by DiLeone, R. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Hazardous Substances DB MORPHINE

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2003, 23(8):3106

BRIEF COMMUNICATION
Involvement of the Lateral Hypothalamic Peptide Orexin in Morphine Dependence and Withdrawal

Dan Georgescu¹, Venetia Zachariou¹, Michel Barrot^{1, 3}, Michihiro Mieda², Jon T. Willie², Amelia J. Eisch¹, Masashi Yanagisawa², Eric J. Nestler¹, and Ralph J. DiLeone¹

¹ Department of Psychiatry, and ² Department of Molecular Genetics and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9070, and ³ Unité Mixte de Recherche 7519, Centre National de la Recherche Scientifique, University Louis Pasteur, 67084 Strasbourg, France

The lateral hypothalamus (LH) is implicated in the behavioral actions of drugs of abuse, but the cellular and molecular basis of this role is unclear. Recent identification of neuropeptides localized in LH neurons has allowed for more specific studies of LH function. The LH-specific peptide orexin (hypocretin) has been shown to be important in arousal and sleep regulation. However, orexin cells of the LH project broadly throughout the brain such that orexin may influence other behaviors as well. In this study, we show that orexin neurons, and not nearby LH neurons expressing melanin-concentrating hormone (MCH), have µ-opioid receptors and respond to chronic morphine administration and opiate antagonist-precipitated morphine withdrawal. cAMP response element-mediated transcription is induced in a subset of orexin cells, but not MCH cells, after exposure to chronic morphine or induction of withdrawal. Additionally, c-Fos and the orexin gene itself are induced in orexin cells in the LH during morphine withdrawal. Finally, we show that orexin knock-out mice develop attenuated morphine dependence, as indicated by a less severe antagonist-precipitated withdrawal syndrome. Together, these studies support a role for the orexin system in molecular adaptations to morphine, and demonstrate dramatic differences in molecular responses among different populations of LH neurons.

Key words: µ-opioid receptor; CREB; c-Fos; melanin-concentrating hormone; opiate withdrawal; drug addiction

---

Copyright © 2003 Society for Neuroscience  0270-6474/03/2383106-06$05.00/0

This article has been cited by other articles:

				M. Lutter, V. Krishnan, S. J. Russo, S. Jung, C. A. McClung, and E. J. Nestler Orexin Signaling Mediates the Antidepressant-Like Effect of Calorie Restriction J. Neurosci., March 19, 2008; 28(12): 3071 - 3075. [Abstract] [Full Text] [PDF]

				Y. Li and A. N. van den Pol {micro}-Opioid Receptor-Mediated Depression of the Hypothalamic Hypocretin/Orexin Arousal System J. Neurosci., March 12, 2008; 28(11): 2814 - 2819. [Abstract] [Full Text] [PDF]

				S. Schwartz, A. Ponz, R. Poryazova, E. Werth, P. Boesiger, R. Khatami, and C. L. Bassetti Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy Brain, February 1, 2008; 131(2): 514 - 522. [Abstract] [Full Text] [PDF]

				C. S. McPherson, T. Featherby, E. Krstew, and J. L. Andrew Quantification of Phosphorylated cAMP-Response Element-Binding Protein Expression throughout the Brain of Amphetamine-Sensitized Rats: Activation of Hypothalamic Orexin A-Containing Neurons J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 805 - 812. [Abstract] [Full Text] [PDF]

				H. Zheng, L. M. Patterson, and H.-R. Berthoud Orexin Signaling in the Ventral Tegmental Area Is Required for High-Fat Appetite Induced by Opioid Stimulation of the Nucleus Accumbens J. Neurosci., October 10, 2007; 27(41): 11075 - 11082. [Abstract] [Full Text] [PDF]

				R. H. Williams, L. T. Jensen, A. Verkhratsky, L. Fugger, and D. Burdakov Control of hypothalamic orexin neurons by acid and CO2 PNAS, June 19, 2007; 104(25): 10685 - 10690. [Abstract] [Full Text] [PDF]

				H. Huang, C. Acuna-Goycolea, Y. Li, H. M. Cheng, K. Obrietan, and A. N. van den Pol Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal J. Neurosci., May 2, 2007; 27(18): 4870 - 4881. [Abstract] [Full Text] [PDF]

				Y. Li and A. N. van den Pol Differential Target-Dependent Actions of Coexpressed Inhibitory Dynorphin and Excitatory Hypocretin/Orexin Neuropeptides J. Neurosci., December 13, 2006; 26(50): 13037 - 13047. [Abstract] [Full Text] [PDF]

				Y. Zhou, J. Bendor, L. Hofmann, M. Randesi, A. Ho, and M. J. Kreek Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol., October 1, 2006; 191(1): 137 - 145. [Abstract] [Full Text] [PDF]

				C. O. Alberto, R. B. Trask, M. E. Quinlan, and M. Hirasawa Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons J. Neurosci., September 27, 2006; 26(39): 10043 - 10050. [Abstract] [Full Text] [PDF]

				X. Xie, T. L. Crowder, A. Yamanaka, Stephen. R. Morairty, R. D. LeWinter, T. Sakurai, and T. S. Kilduff GABAB receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus J. Physiol., July 15, 2006; 574(2): 399 - 414. [Abstract] [Full Text] [PDF]

				M. Narita, Y. Nagumo, S. Hashimoto, M. Narita, J. Khotib, M. Miyatake, T. Sakurai, M. Yanagisawa, T. Nakamachi, S. Shioda, et al. Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine J. Neurosci., January 11, 2006; 26(2): 398 - 405. [Abstract] [Full Text] [PDF]

				B. Boutrel, P. J. Kenny, S. E. Specio, R. Martin-Fardon, A. Markou, G. F. Koob, and L. de Lecea Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior PNAS, December 27, 2005; 102(52): 19168 - 19173. [Abstract] [Full Text] [PDF]

				D. Georgescu, R. M. Sears, J. D. Hommel, M. Barrot, C. A. Bolanos, D. J. Marsh, M. A. Bednarek, J. A. Bibb, E. Maratos-Flier, E. J. Nestler, et al. The Hypothalamic Neuropeptide Melanin-Concentrating Hormone Acts in the Nucleus Accumbens to Modulate Feeding Behavior and Forced-Swim Performance J. Neurosci., March 16, 2005; 25(11): 2933 - 2940. [Abstract] [Full Text] [PDF]

				V. Zachariou, D. Georgescu, N. Sanchez, Z. Rahman, R. DiLeone, O. Berton, R. L. Neve, L. J. Sim-Selley, D. E. Selley, S. J. Gold, et al. Essential role for RGS9 in opiate action PNAS, November 11, 2003; 100(23): 13656 - 13661. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help